>
pdufa.bio

IMVT-1402

Updated ยทnext FDA decision on the calendar

IMVT-1402 is a Immunovant, Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

IMVT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Immunovant, Inc. (IMVT). We track 2 catalyst events for this program: 2 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026IMVTReadout · Sep 2027IMVT

Questions

When is IMVT-1402's next FDA decision or readout?

The next tracked catalyst for IMVT-1402 is a Readout in Oct 2026.

What happened at IMVT-1402's most recent FDA decision?

No FDA decision for IMVT-1402 is in our archive yet.

Who makes IMVT-1402?

Immunovant, Inc. (IMVT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.